| Ms Megan Ann Pelletier, FNP-C | |
|
8 Pikes Hl, Norway, ME 04268-5340 | |
| (207) 744-6444 | |
| Not Available |
| Full Name | Ms Megan Ann Pelletier |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 8 Pikes Hl, Norway, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023797917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CNP231240 (Maine) | Primary |
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
A new study could point the way to the development of better drugs to fight a deadly form of childhood leukemia called mixed-lineage leukemia (MLL).
A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute.
A new article has been published in Cellular and Molecular Lifesciences, which focuses on the connection between host factors and the worsening of the COVID-19. Further, the impact of the virus on the host's microbiome and secondary infection has also been studied.
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.s
EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Megan Ann Pelletier, FNP-C 93 Gamage Ave Apt 1b, Auburn, ME 04210-4766 Ph: (207) 212-8651 | Ms Megan Ann Pelletier, FNP-C 8 Pikes Hl, Norway, ME 04268-5340 Ph: (207) 744-6444 |
News Archive
A new study could point the way to the development of better drugs to fight a deadly form of childhood leukemia called mixed-lineage leukemia (MLL).
A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute.
A new article has been published in Cellular and Molecular Lifesciences, which focuses on the connection between host factors and the worsening of the COVID-19. Further, the impact of the virus on the host's microbiome and secondary infection has also been studied.
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.s
EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.
› Verified 3 days ago
Anne Mcmath, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 193 Main St Ste 9, Norway, ME 04268 Phone: 207-743-8766 Fax: 207-743-1579 | |
Laura E Jackson, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8 Pikes Hl, Norway, ME 04268 Phone: 207-744-6444 | |
Jennifer Rebecca Blastow, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 193 Main St, Suite 1, Norway, ME 04268 Phone: 207-743-7721 Fax: 207-743-6306 | |
Emily Karonis, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 193 Main St, Norway, ME 04268 Phone: 207-743-8766 | |
Elizabeth Kern, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Norway, ME 04268 Phone: 207-743-7605 | |
James P Lepich, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Pikes Hl, Norway, ME 04268 Phone: 207-743-8031 Fax: 207-743-6672 |